SOURCE: BioCentric Energy Holdings, Inc.

BioCentric Energy Holdings, Inc.

March 16, 2010 13:14 ET

BioCentric Energy Announces Appointment of Dr. Brian Goodall as CEO

SANTA ANA, CA--(Marketwire - March 16, 2010) -  BioCentric Energy Holdings, Inc. (PINKSHEETS: BEHL) today announced... BioCentric Energy Holdings, Inc. has appointed Dr. Brian Goodall as the Company's new Chief Executive Officer. As a corporate honoree at the National Inventors Hall of Fame and an impressive career spanning 30+ years in the USA and Europe, Dr. Goodall has worked for companies such as the Royal Dutch/Shell group in Amsterdam and BF Goodrich. While working for a major US Biofuels producer, Imperium Renewables, Dr. Goodall led the team that made the jet fuel for the first-ever commercial test flight (Virgin Atlantic, London) in February 2008. 

Holding several Executive positions in the petrochemical, energy and renewable energy sectors, Dr. Goodall, was most recently the Vice President of Downstream Technology for Sapphire Energy, (located in San Diego, CA), where he was instrumental in enabling the use of algal-derived jet fuel in the first US commercial test flight (Continental Airlines, Houston) in January 2009 and algal derived fuel for the Algaeus cross-country drive in the late summer of 2009. Sapphire is well known in the algae sector for their utilization of open-pond algae systems to generate 'green crude' and drop-in replacement diesel, jet fuel and gasoline. 

With over 80 patents and 60 published papers in the scientific journals, while at Shell Dr. Goodall invented SHAC (Super High Activity Catalyst) catalyst, which is used commercially to make more than 1/3 of the world's polypropylene, and launched a new company, Promerus (now owned by Sumitoma Bakelite), in the electronic materials sector while at BF Goodrich.

In addition to Dr. Goodall's experience and proven record of commercial success, his strengths have been in identifying, developing and bringing to fruition innovative technologies that are commercially viable, such as BioCentric Energy's low-cost Photobioreactor system. Also, Dr. Goodall brings to BioCentric Energy his unwavering professionalism and ability in creating strong and beneficial relationships with individuals and companies around the world.

The BioCentric Energy team strongly believes that Dr. Goodall is highly qualified and capable of taking the Company to the next level in manufacturing, implementing systems and cost-effectively delivering commercial algae products to the global marketplace in 2010.

Dr. Goodall stated today, "I am excited to become part of the BioCentric Energy team and the opportunity to bring this new photobioreactor and algae technology to commercial reality. I am confident that we can start to unlock the profitable potential of algae in the short term, as well as making strides towards delivering the longer-term value of aquatics in the energy and bulk petrochemical markets."

BioCentric Energy has worked diligently to complete the renovations to the custom-designed sterile algae lab which is now being deployed in preparation of the Company's new R&D equipment.

A clean sterile laboratory is essential for testing, incubating and subsequently inoculating the Company's proprietary algae strains, which will be mass-produced in the commercial units. Algae Specialist Domini Maddox arrived from Texas and began her first day at the BioCentric Energy headquarters in Santa Ana on Monday.

The Company continues to receive daily inquires from some potentially large clients expressing interest in BioCentric Energy's closed-loop systems and algae derived products.

VOD Newswire Video Format:
http://vodnewswire.com/vodnewswire/news/biocentric-energy-20100316/

Safe Harbor Statement: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by phrases such as BEHL or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements.

All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.

Contact Information